Industry Dialogue 2019/2

CRM Industry Dialogue provides an avenue for Pharmaceutical companies (sponsors) and CROs to directly convey any issues, suggestions or opinions that they may have to CRM. Besides strengthening cooperation and networking between all parties, CRM also takes the opportunity to update the clinical research industry on local laws, guidelines and regulations. By bringing together these industry players, CRM uses this platform to connect with them and provide updates on its current and future activities.

Guest Speakers

We wish to express our sincere gratitude to our special guests, Dato’ Dr Goh Pik Pin (Director, Institute for Clinical Research) and Mr Ewe Kheng Huat (Executive Director of the Pharmaceutical Association of Malaysia (PhAMA))

Dato’ Dr Goh Pik Pin (Director, Institute for Clinical Research)

Mr Ewe Kheng Huat (Executive Director of the Pharmaceutical Association of Malaysia (PhAMA))

We also would like to thank our guest speakers Mr Normanshally Mohammad (Associate Director of Clinical Operations, Merck Sharp and Dohme), Mdm Aiza Adlina Abdullah (Senior Principal Assistant Director, NPRA), Dr Asyraf Syahmi Mohd Noor (MREC Secretariat), Mdm Aidahwaty Ariffin @ M. Olaybal (Head of Technical Evaluation Division, MDA) for sharing important updates with us today.

Mr Normanshally Mohammad (Associate Director of Clinical Operations, Merck Sharp and Dohme)

 

Mdm Aiza Adlina Abdullah (Senior Principal Assistant Director, NPRA)

 

Dr Asyraf Syahmi Mohd Noor (MREC Secretariat)

 

Mdm Aidahwaty Ariffin @ M. Olaybal (Head of Technical Evaluation Division, MDA)

Dialogue Session

We invited all of the special guests and speakers including our Senior Leadership Team (Dr Akhmal Yusof, Ms Joanne Yeoh, Ms Audrey Ooi, and Mr Yau Yit Huan) to have a dialogue session with the industry players. CRM has actively engaged and received feedback from the industry players in the dialogue session to move forward. We are also taking all the constructive feedback into consideration to improve our services and as an aspiration to deliver study with speed, reliability and quality.

Our humble gratitude to all that has make this event successful.